Who we are: atai is a biopharmaceutical company that leverages a decentralised platform approach to incubate and accelerate the development of highly effective mental health treatments that address the unmet needs of patients. Our vision: To heal mental health disorders so that everyone, everywhere can live a more fulfilled life. Our approach: By pooling expertise, best practices, and resources across our entire portfolio, we mitigate risk and responsibly accelerate the development of impactful and evidence-based treatments.
4
Total Investments
3
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Health Care
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About ATAI Life Sciences
Recent Investments (4)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Merger | •••••• | Jun 2025 | |
| Late Vc | •••••• | Jan 2024 | |
| Post-IPO Equity | •••••• | Aug 2023 | |
| Series B | •••••• | Apr 2020 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.